FMAGX
Price
$15.06
Change
-$0.04 (-0.26%)
Updated
Sep 20 closing price
RGEBX
Price
$73.82
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

FMAGX vs RGEBX

Header iconFMAGX vs RGEBX Comparison
Open Charts FMAGX vs RGEBXBanner chart's image
Fidelity Magellan
Price$15.06
Change-$0.04 (-0.26%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.82
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FMAGX vs RGEBX Comparison Chart
Loading...
VS
FMAGX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAGX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 290B vs. FMAGX (35.6B). FMAGX pays higher dividends than RGEBX: FMAGX (0.33) vs RGEBX (0.16). FMAGX was incepted earlier than RGEBX: FMAGX (61 years) vs RGEBX (10 years). FMAGX is a more actively managed with annual turnover of: 86.00 vs. RGEBX (31.00). FMAGX has a lower initial minimum investment than RGEBX: FMAGX (0) vs RGEBX (250). FMAGX annual gain was more profitable for investors over the last year : 37.04 vs. RGEBX (29.29). RGEBX return over 5 years is better than : 50.58 vs. FMAGX (39.07).
FMAGXRGEBXFMAGX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence61 years10 years-
Gain YTD22.40021.295105%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets35.6B290B12%
Annual Yield % from dividends0.330.16211%
Returns for 1 year37.0429.29126%
Returns for 3 years4.13-1.04-397%
Returns for 5 years39.0750.5877%
Returns for 10 years60.6462.1198%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTNP5.660.10
+1.80%
Titan Pharmaceuticals
INCR1.870.01
+0.54%
Intercure Ltd
Z67.09-0.75
-1.11%
Zillow Group
BATRA43.56-0.64
-1.45%
Atlanta Braves Holdings
ALLO2.81-0.11
-3.61%
Allogene Therapeutics